Search
Showing results for "clinical trials"
Consumer Representative Lauren Hope-Blyth
News & Events
The Kids Research Institute Australia leader named finalist in nation’s top science prizesOne of Australia’s leading infectious disease experts, Associate Professor Asha Bowen, has been announced as a finalist for the country’s leading national science awards – the Australian Museum Eureka Prizes.
News & Events
Universal protocols for Strep A surveillance set to transform research for world-first vaccineA global consortium of Group A Streptococcus (Strep A) researchers has launched a series of best practice surveillance protocols designed to unite international research efforts for a world-first Strep A vaccine.
Our team aims to optimise lung health early in life to ensure the best possible health outcomes later in life.
Research
The END RHD CRE: Developing an end game for rheumatic heart disease in AustraliaThe END RHD CRE will undertake a number of projects across several disciplines of research including epidemiology, biomedical sciences; implementation and translation; and understanding the RHD community with a special focus on documenting the experiences of those living with the disease.
Research
Autism and intellectual disability are differentially related to sociodemographic background at birthWe used population data on Western Australian singletons born from 1984 to 1999 (n = 398,353) to examine the sociodemographic characteristics of children...
Research
Kids Easy Breathing StudyAs both bronchiolitis and bronchiectasis are diseases of the airway surface, we will comprehensively study the airway surface and factors affecting the airway surface in infants hospitalised with bronchiolitis.
Research
Sexually dimorphic facial features vary according to level of autistic-like traits in the general populationThe current data provide support for Bejerot et al.'s androgyny account since males and females with high levels of autistic-like traits generally showed...
Research
Improving delivery of secondary prophylaxis for rheumatic heart diseaseContinued progress in controlling RHD requires an understanding of how to improve delivery of regular injections of penicillin - secondary prophylaxis (SP).